Recursion Pharmaceuticals (RXRX) Earnings Date & Reports
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RXRX is expected to report earnings to fall 28.80% to -35 cents per share on August 12
Q2'25
Est.
$-0.36
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.12
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.02
The last earnings report on May 05 showed earnings per share of -50 cents, missing the estimate of -49 cents. With 22.73M shares outstanding, the current market capitalization sits at 1.85B.